Research findings have consistently demonstrated that NEAT1 plays a role in the advancement of multiple cancer types, encompassing breast cancer, LCs, hepatocellular carcinoma (HCC), ovarian cancer, and prostate cancer (Fang et al., 2017[14]; Klec et al., 2019[34]; Liu et al., 2018[51]; Xiong et al., 2018[82]). Here, NEAT1 is linked to ovarian cancer.